의약품 포장 시장 - 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Pharmaceutical Packaging Market was valued at USD 151.5 billion in 2024 and is anticipated to expand at a CAGR of 15.6% from 2025 to 2034. The rising demand for biopharmaceuticals and the increasing emphasis on tamper-evident and child-resistant packaging are key factors driving growth. Advances in biologics and the surge in personalized medicine are accelerating the need for specialized packaging solutions that ensure stability and efficacy. As a result, companies are ramping up research and development efforts to introduce innovative materials and formats that align with stringent regulatory requirements.

The pharmaceutical industry's growing reliance on advanced packaging to preserve complex biological formulations presents new opportunities for manufacturers. Cryogenic and temperature-sensitive packaging solutions are gaining traction to address the storage and transportation needs of biopharmaceuticals. Additionally, the heightened focus on patient safety and stringent regulations are pushing companies to invest in protective packaging concepts that prevent accidental ingestion. Pharmaceutical firms are incorporating smart features such as RFID-enabled tracking and temperature indicators to improve drug traceability and adherence.

The market is categorized into primary, secondary, and tertiary packaging. Primary packaging is projected to surpass USD 431.2 billion by 2034. The demand for smart and interactive packaging, including child-resistant and tamper-proof solutions, is increasing as manufacturers prioritize drug safety and compliance. The expansion of biologics and personalized medicine is further fueling the need for high-barrier materials that maintain product integrity.

Based on material, the market is divided into plastics and polymers, paper and paperboard, glass, and metal. Plastics and polymers accounted for 43.4% of the total market share in 2024, serving as the preferred choice due to their versatility, lightweight nature, and durability. Sustainability concerns are driving the adoption of bio-based, recyclable, and biodegradable plastics to reduce environmental impact and meet evolving regulatory standards.

The market is also segmented by product type, including bottles, syringes, blister packs, vials and ampoules, sachets, pouches, and medication tubes. Bottles led the segment, generating USD 45.3 billion in 2024. The pharmaceutical industry continues to favor bottles for solid and liquid drug packaging due to their convenience and ease of use. The shift toward sustainable alternatives, including recycled and bio-based plastic bottles, reflects growing efforts to minimize ecological footprint.

By application, the market includes oral drugs, injectable drugs, topical drugs, nasal drugs, and intravenous drugs. Oral drug packaging reached USD 52.5 billion in 2024, with blisters, bottles, and sachets remaining the most utilized formats. Enhanced child-resistant designs and built-in indicators to track dosages are gaining popularity, supporting medication adherence and safety.

North America led the global pharmaceutical packaging market with a 34.8% share in 2024. The United States alone contributed USD 46.1 billion, driven by strict regulatory frameworks and substantial investments in medicine production and healthcare advancements.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing innovation in novel drug packaging systems
    • 3.2.1.2 Rising demand for biopharmaceuticals
    • 3.2.1.3 Increasing prevalence of chronic diseases
    • 3.2.1.4 Increasing use of advanced drug delivery systems
    • 3.2.1.5 Rising demand for child-resistant and tamper-evident features in packaging
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Counterfeit drugs and fake packaging
    • 3.2.2.2 Limited or Inadequate access to quality medical care
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 (USD Bn & Kilo Tons)

• 5.1 Key trends
• 5.2 Blister packs
• 5.3 Bottles
• 5.4 Syringes
• 5.5 Vials & ampoules
• 5.6 Sachets
• 5.7 Pouches
• 5.8 Medication tubes
• 5.9 Others

Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2034 (USD Bn & Kilo Tons)

• 6.1 Key trends
• 6.2 Plastics
  • 6.2.1 Polyethylene (PE)
  • 6.2.2 Polyethylene terephthalate (PET)
  • 6.2.3 Polypropylene (PP)
  • 6.2.4 Polystyrene (PS)
  • 6.2.5 Polyvinyl chloride (PVC)
  • 6.2.6 Others
• 6.3 Paper & paperboard
• 6.4 Glass
• 6.5 Metal

Chapter 7 Market Estimates and Forecast, By Packaging Type, 2021 – 2034 (USD Bn & Kilo Tons)

• 7.1 Key trends
• 7.2 Primary packaging
• 7.3 Secondary packaging
• 7.4 Tertiary packaging

Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2034 (USD Bn & Kilo Tons)

• 8.1 Key trends
• 8.2 Oral drugs
• 8.3 Injectable drugs
• 8.4 Topical drugs
• 8.5 Nasal drugs
• 8.6 Intravenous (IV) drugs
• 8.7 Others

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Bn & Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Adelphi
• 10.2 Amcor
• 10.3 Aptar CSP Technologies
• 10.4 Berry Global
• 10.5 Catalent
• 10.6 CCL Industries
• 10.7 Comar
• 10.8 Constantia Flexibles
• 10.9 Drug Plastics & Glass
• 10.10 DS Smith
• 10.11 Eastman Chemical
• 10.12 Gerresheimer
• 10.13 Huhtamaki
• 10.14 Mayr-Melnhof Karton
• 10.15 Nipro
• 10.16 Origin Pharma Packaging
• 10.17 ProAmpac
• 10.18 Schott Pharma
• 10.19 SGD Pharma
• 10.20 Silgan
• 10.21 Sonoco
• 10.22 West Pharmaceutical
• 10.23 WestRock